Sharanya Ford - AbbVie Inc | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Upadacitinib improves symptomatic responses in patients with moderately to severely active Crohn's disease

I. Blumenstein, J. Torres, C. Ma,J. O. Lindsay,R. Ungaro,L. Thin,A. P. Lacerda, S. I. Anyanwu,A. Garrison,S. Ford,E. Louis

JOURNAL OF CROHNS & COLITIS (2024): II000-I1001

引用0浏览0引用

Characterisation of endoscopic improvement in Crohn's Disease with upadacitinib treatment

R. Panaccione,G. Y. Melmed, R. Khanna,G. D'Haens,S. Danese,S. Ford, S. I. Anyanwu,A. Garrison,A. P. Lacerda,S. Vermeire

JOURNAL OF CROHNS & COLITIS (2024): I156-I157

引用0浏览0引用

Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn’s Disease Regardless of Prior Biologic Exposure

Laurent Peyrin-Biroulet,Remo Panaccione,Edouard Louis,Raja Atreya,David T. Rubin,James O. Lindsay,Jesse Siffledeen, Dana J. Lukin,John Wright,Kenji Watanabe,Sharanya Ford,Valencia P. Remple,Ana P. Lacerda,Elena Dubcenco,Andrew Garrison,Qian Zhou,Sofie Berg,Samuel I. Anyanwu,Stefan Schreiber

CLINICAL GASTROENTEROLOGY AND HEPATOLOGYno. 10 (2024): 2096-2106

引用0浏览0WOS引用

OP10 Efficacy and Safety of Upadacitinib in Patients with Moderately to Severely Active Crohn’s Disease: Results from the U-ENDURE Long-Term Extension

G. D'Haens,E. Louis,E. V. Loftus,M. Regueiro,V. Jairath,F. Magro,H. Nakase,E. Dubcenco,A. P. Lacerda,T. Feng, B. Duncan, T. Wang,S. Ford, S. I. Anyanwu,I. Blumenstein

JOURNAL OF CROHNS & COLITIS (2024): I17-I18

引用0浏览0引用

Su1798 UPADACITINIB TREATMENT IS ASSOCIATED WITH IMPROVED CLINICAL AND QUALITY OF LIFE OUTCOMES IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE U-ENDURE LONG-TERM EXTENSION

David T. Rubin,Edouard Louis,Julián Panés,Astrid Rausch,Luc Biedermann,Yoichi Kakuta,Elena Dubcenco,Ana P. Lacerda,Tian Feng,Benjamin Duncan, Tao Wang,Sharanya Ford,Samuel Anyanwu,Namita Joshi,Peter Bossuyt

Gastroenterologyno. 5 (2024): S-818-S-819

引用0浏览0引用

Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy

Jean-Frederic Colombel,Tadakazu Hisamatsu,Raja Atreya,Francesca Bresso,Lena Thin,Remo Panaccione,Rogerio Serafim Parra,Sharanya Ford,Valencia P. Remple,Ana Paula Lacerda, Samuel I. Anyanwu,Madhuja Mallick,Andrew Garrison,Miguel Regueiro

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY（2024）

引用0浏览0WOS引用

P630 Upadacitinib Improves Clinical Outcomes in Patients with Moderate to Severely Active Crohn’s Disease Irrespective of Previous Failure to Respond to Biologics or Conventional Therapies

S Schreiber,A. J. Lim,Ana P. Lacerda,Jessica R. Allegretti,Kenji Watanabe,Dana J. Lukin, E Dubenco,Sharanya Ford,Jessica Oomen,Qian Zhou,J Liu,Édouard Louis

Journal of Crohn s and Colitis（2023）

引用1浏览0引用

1031 UPADACITINIB IMPROVES ENDOSCOPIC OUTCOMES IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE CROHN'S DISEASE IRRESPECTIVE OF PREVIOUS FAILURE TO RESPOND TO BIOLOGICS OR CONVENTIONAL THERAPIES

Brian G. Feagan,Sara Horst,Gerald W. Dryden,James O. Lindsay,Marc Ferrante,Elena Dubcenco,Ana P. Lacerda,Sharanya Ford,Samuel Anyanwu,Qian Zhou,Jianzhong Liu,Minhu Chen,Stefan Schreiber

Gastroenterologyno. 6 (2023): S-223

引用0浏览0引用

Tu1723 ENDOSCOPIC AND CLINICAL OUTCOMES OF UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE BY NUMBER AND TYPE OF PRIOR BIOLOGICS

Laurent Peyrin–Biroulet,Gareth Parkes,Cristina Rodríguez Gutiérrez,Jesse Siffledeen,John Paul Wright,Efrat Broide,Sharanya Ford,Ana P. Lacerda,Jessica Oomen,Andrew Garrison,Sofie Berg,David T. Rubin

Gastroenterology（2023）

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn